Point72 Asset Management
WST icon

Point72 Asset Management’s West Pharmaceutical WST Stock Holding History

Point72 Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.9M Sell
159,350
-75,687
-32% -$18.8M 0.05% 468
2025
Q4 		$64.7M Sell
235,037
-424,216
-64% -$116M 0.07% 315
2025
Q3 		$173M Buy
659,253
+319,300
+94% +$77.6M 0.29% 51
2025
Q2 		$74.4M Buy
339,953
+211,666
+165% +$45.2M 0.15% 167
2025
Q1 		$28.7M Sell
128,287
-74,185
-37% -$20.4M 0.07% 347
2024
Q4 		$66.3M Buy
+202,472
New +$63.7M 0.15% 158
2024
Q2 		– Sell
-112,107
Closed -$44.4M – 2522
2024
Q1 		$44.4M Buy
112,107
+4,516
+4% +$1.67M 0.11% 229
2023
Q4 		$37.9M Sell
107,591
-76,000
-41% -$26.9M 0.09% 272
2023
Q3 		$68.9M Buy
+183,591
New +$71M 0.2% 112
2023
Q2 		– Sell
-174,599
Closed -$60.5M – 2857
2023
Q1 		$60.5M Buy
174,599
+174,065
+32,596% +$50.9M 0.19% 135
2022
Q4 		$126K Buy
+534
New +$127K ﹤0.01% 1293
2021
Q4 		– Sell
-24,728
Closed -$10.5M – 1329
2021
Q3 		$10.5M Sell
24,728
-5,400
-18% -$2.28M 0.05% 475
2021
Q2 		$10.8M Sell
30,128
-16,729
-36% -$5.53M 0.05% 430
2021
Q1 		$13.2M Buy
46,857
+8,739
+23% +$2.5M 0.06% 362
2020
Q4 		$10.8M Sell
38,118
-23,591
-38% -$6.62M 0.05% 426
2020
Q3 		$17M Sell
61,709
-9,588
-13% -$2.54M 0.09% 304
2020
Q2 		$16.2M Buy
71,297
+41,316
+138% +$8.12M 0.11% 247
2020
Q1 		$4.57M Sell
29,981
-97,212
-76% -$15M 0.04% 394
2019
Q4 		$19.1M Buy
127,193
+90,195
+244% +$13.1M 0.1% 265
2019
Q3 		$5.25M Buy
36,998
+35,798
+2,983% +$4.93M 0.03% 446
2019
Q2 		$150K Buy
+1,200
New +$142K ﹤0.01% 1000

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's WST Position: Q1 2026 in Review

Point72 Asset Management reduced its West Pharmaceutical (WST) stake by 32% in Q1 2026, selling an estimated $18.8M and leaving 159,350 shares worth $39.9M. The position accounts for 0.05% of the portfolio, ranked #468.

Point72 Asset Management first reported a position in WST in Q2 2019 and has held it in 21 quarters since. The position peaked at $173M in Q3 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Point72 Asset Management held 159,350 shares of West Pharmaceutical worth $39.9M as of Q1 2026.
  • Point72 Asset Management sold 75,687 West Pharmaceutical shares in Q1 2026, an estimated $18.8M.
  • West Pharmaceutical made up 0.05% of Point72 Asset Management's portfolio in Q1 2026, its #468 holding.
  • Point72 Asset Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 21 quarters since.
  • Point72 Asset Management's West Pharmaceutical position peaked at $173M in Q3 2025.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.